Bain Capital Life Sciences Opportunities IV, L.P. — insider trades

Stock trades Bain Capital Life Sciences Opportunities IV, L.P. reported on SEC Form 4 at OLMA Olema Pharmaceuticals, Inc..

• Jan 8, 2025: bought 300,000 shares of OLMA Olema Pharmaceuticals, Inc. ($1.73M)